nach oben

European Journal of Nuclear Medicine and Molecular Imaging

Erschienen in:

13.02.2020 | Correction

Correction to: A new Centiloid method for ¹⁸F-florbetaben and ¹⁸F-flutemetamol PET without conversion to PiB

verfasst von: Soo Hyun Cho, Yeong Sim Choe, Hee Jin Kim, Hyemin Jang, Yeshin Kim, Si Eun Kim, Seung Joo Kim, Jun Pyo Kim, Young Hee Jung, Byeong C. Kim, Suzanne L. Baker, Samuel N. Lockhart, Duk L. Na, Seongbeom Park, Sang Won Seo

Erschienen in: European Journal of Nuclear Medicine and Molecular Imaging | Ausgabe 6/2020

Einloggen, um Zugang zu erhalten

Excerpt

Correction to: European Journal of Nuclear Medicine and Molecular Imaging …

Titel: Correction to: A new Centiloid method for 18F-florbetaben and 18F-flutemetamol PET without conversion to PiB
verfasst von: Soo Hyun Cho
Yeong Sim Choe
Hee Jin Kim
Hyemin Jang
Yeshin Kim
Si Eun Kim
Seung Joo Kim
Jun Pyo Kim
Young Hee Jung
Byeong C. Kim
Suzanne L. Baker
Samuel N. Lockhart
Duk L. Na
Seongbeom Park
Sang Won Seo
Publikationsdatum: 13.02.2020
Verlag: Springer Berlin Heidelberg
Erschienen in: European Journal of Nuclear Medicine and Molecular Imaging / Ausgabe 6/2020
Print ISSN: 1619-7070
Elektronische ISSN: 1619-7089
DOI: https://doi.org/10.1007/s00259-020-04692-3

Springer Medizin

Excerpt

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 6/2020

TSPO PET, tumour grading and molecular genetics in histologically verified glioma: a correlative 18F-GE-180 PET study

Non-invasive tumor decoding and phenotyping of cerebral gliomas utilizing multiparametric 18F-FET PET-MRI and MR Fingerprinting

FDG-PET/CT in the detection of pituitary stalk ACTH-secreting adenoma

“Quid autem vides festucam in oculo fratris tui et trabem in oculo tuo non vide” on the hyperthyroidism-induced mortality and antithyroid drug-induced side effects in the era of radioiodine fake news

Integration of PET-imaging into radiotherapy treatment planning for low-grade meningiomas improves outcome

Correlation of hypoxia as measured by fluorine-18 fluoroerythronitroimidazole (18F-FETNIM) PET/CT and overall survival in glioma patients